videoSlug

VideoSlug_VideoQuery

slug

VideoPageContentQuery

content

videos

query VideoSlug_VideoQuery(
  $videoSlug: String!
) {
  ...VideoPageContentQuery_1X4EH4
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment LatestVideos_Videos on Query {
  videos(first: 5, upcoming: false, order: {field: liveTime, direction: DESC}) {
    edges {
      node {
        id
        title
        lang
        pageUrl
        liveTime
        isLive
        companies {
          name
          squareLogoUrl
          id
        }
      }
    }
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment VideoPageContentQuery_1X4EH4 on Query {
  content(slug: $videoSlug, type: [VIDEO, WEBCAST]) {
    __typename
    id
    title
    slug
    lang
    htmlBody
    isPremium
    companies {
      viewerIsFollowing
      id
      name
      pageUrl
      defaultInstrument {
        id
        isin
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    createdAt
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    ... on Video {
      imgUrl
      videoEmbedUrl(location: "inderes")
      audioEmbedUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ... on Webcast {
      imgUrl
      videoEmbedUrl(location: "inderes")
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
  }
  ...LatestVideos_Videos
}


type

__typename

title

lang

htmlBody

isPremium

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

first

order

upcoming

edges

Cyxone

 Cyxone, a swedish based biotech company active within the area of autoimmune diseases will participate at a digital event hosted by HC Andersen Capital on Friday April 29th where the CEO of...

<div>
<div class="WordSection1">
<div class=""><span class="" lang="EN-US">Cyxone, a swedish based biotech company active within the area of autoimmune diseases will participate at a digital event hosted by HC Andersen Capital on Friday April 29th where the CEO of Cyxone Tara Heitner will present to give an introduction of the company. Cyxone develops therapies for the two autoimmune diseases rheumatoid arthritis (RA) and multiple sclerosis, where its primary product candidate, Rabexiomed, for RA is in phase 2 and T20K for multiple sclerosis is in Phase 1. </span></div>
<div></div>
<div class=""><span class="" lang="EN-US">At the event you will get the opportunity to hear more about Cyxone and its product pipeline. Topics for questions and discussion could be the upcoming phase 2b study for RA, the market opportunity for its product candidates and potential for multi-indication of Rabexiomed, its partner and licensing strategy as well as the financial position of the company following the recent rights issue where Cyxone raised more than SEK 60 million.</span></div>
<div></div>
</div>
</div>
<div class=""><span class="" lang="EN-US">*HC Andersen Capital receives payment from Cyxone for a DigitalIR/Corporate Visibility agreement.</span></div>

HC Andersen Capital

Cyxone - Introduction to the share, 29.04.2022

Verve Group

A sit-down with CEO Remco Westermann

Aiforia Technologies

Aiforia as an Investment | Life Science Night Dec  9, 2025

Endomines Finland

Endomines as an Investment | Investor Day Nov. 24, 2025

Clas Ohlson

Clas Ohlson, Audiocast, Q2'25

Herantis Pharma

Herantis Pharma as an Investment | Life Science Night Dec  9, 2025

Recent videos